FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021

Page created by Clifford Oconnor
 
CONTINUE READING
FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021
FY2020 results
Recovery dynamic engaged in H2, strong ambtitions
for the next years

17 March 2021
FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021
SUMMARY

1. 2020 ACTIVITY : NUMEROUS COMMERCIAL SUCCESSES IN A CHALLENGING ENVIRONEMENT

2. FINANCIAL RESULTS: RECOVERY ENGAGED IN H2

3. OUTLOOK : STRONG GROWTH IN 2021 & FOR THE NEXT YEARS

4. APPENDIX

                                                                          2
FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021
2020 ACTIVITY: NUMEROUS OPERATIONAL &
COMMERCIAL SUCCESSES

                                        3
FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021
STRATEGIC POSITION: OFFER TURNKEY SOLUTIONS FOR INDUSTRIAL 3D PRINTING

                                                Expertise on the whole value chain of 3D printing

                                SYSTEMS                                                                 PRODUCTS
                      PRINTERS, MATERIALS, SOFTWARE                                        MANUFACTURING OF PARTS ON DEMAND
                                                                                               AND MEDICAL APPLICATIONS

3D PRINTERS & RAPID           LIQUID RESINS &           3D MODELING            DESIGN & ON-DEMAND           AUDIOLOGY,
                                                                                                                    4 CHIROPODY AND DENTAL
 ADDITIVE FORGING            POLYMER POWDERS             SOFTWARES               MANUFACTURING

                                                                                                                                     4
FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021
COMMERCIAL SUCCESSES DESPITE A CHALLENGING ENVIRONMENT

  Major contracts for liquid resins in                       More sales of Laser Sintering                    Good commercial dynamic on other fronts
              Medical                                                     3D Printers

• Partnership with 2 European specialist & a large     • Q1 2020 : 6 SLS printers sold to three chemical   • Jewelry applications : 2 clients installing a dozen of wax machines
  global player for dental materials                     industry players                                    each

• Several printers LD10 & LD20 installed as well

• Dozens of tons of resins to be consumed once their   • Q4 2020 : New contracts with 2 companies in the   • 3D modeling softwares : largest contract in history in the truck
  production is stabilized                               steel industry & food packaging industry            industry covering a transformation program for 50 design engineers

                                                                                                                                                                     5
FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021
CONSOLIDATE STRATEGIC POSITIONS WITH NEW INNOVATIVE SOLUTIONS FOR CLIENTS

Implementing new innovative solutions for Software and Printers…                                                   …to strengthen Prodways strategic position

Integrate Cloud solutions for 3D Modeling

                                         • Integrating 3DEXPERIENCE® platform of Dassault Systèmes                 Reinforced Software expertise
                                                                                                                   Prodways is now one of the few industrial 3D printer manufacturers
                                         • Offer launched in Europe & United States1
                                                                                                                   worldwide to offer this 3D software expertise

Improving the precision & efficiency of MovingLight printers for aligners applications
                                       • Super-Resolution 3D: new algorithm to reach
FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021
OPERATIONAL TRANSFORMATION TO IMPROVE PROFITABILITY & PRODUCTION CAPACITY

   Final phase of group synergies plan fast-tracked                    Increased production capacity
   Transformation launched in Q4 to continue in 2021                   of Materials for dental applications

    Adapt the fabrication of printers to the ramp-up of the activity
                    and location of the key clients                      Upgrading the production capacity to match
                                                                              strong commercial perspectives
    Transferring the production of the historical workshop in Paris
         region to the existing sites in Annecy and in the US

  More operational synergies by regrouping sites & teams               +50% increase in 8 months to reach 100 tons/year
                Optimizing fixed cost structure
                                                                                                                          7
FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021
FINANCIAL RESULTS : RECOVERY ENGAGED IN H2

                                             8
FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021
FINANCIAL RESULTS : RECOVERY ENGAGED IN H2

                                                                                                                                Var.           Var.
(in €million)                                H1 2019 H2 2019 FY2019 H1 2020 H2 2020                             FY2020        H2 2020        FY2020
                                                                                                                             vs H2 2019     vs FY2019

Revenue                                        35,3         36,0         71,3          26,8         30,4         57,2           -5,6          -14,1              Reduced impact in H2 compared to H1

EBITDA1                                         2,6          2,7          5,3          1,4           1,9          3,3           -0,8           -2,0              Positive EBITDA despite impact on revenues

EBIT2                                          -1,0          -0,5         -1,5         -2,9         -0,9          -3,8          -0,4           -2,3              Limited decrease of Operating income

Operating income                               -2,4          -1,3         -3,8        -10,0         -4,8         -14,8          -3,5          -11,0

Financial result                               -0,1          -0,2         -0,3         -0,2         -0,1          -0,3          +0,1           -0,0

Net income group share                         -2,8          -1,4         -4,2         -8,7         -5,3         -13,9          -3,8           -9,7

  (1) Operating income before "Net depreciation, amortization and provisions", "Other items of operating income" and “Share in the results of associated companies”.
  (2) “Operating income before "Other items of operating income" and “Share in the results of associated companies”.                                                                                          9
FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021
SYSTEMS DIVISION: TOP LINE IMPACTED BY MACRO SITUATION BUT RESILIENT EBITDA

                Revenues impacted by wait & see                                                                                  Limited EBITDA1 decrease (€m)
                environnement
                                                      -€4,4 m

                                            23,6                                                                                                                  8.6%           8.0%
                                                                                                                                                                 margin         margin
                                                                 19,2
                                                                                                                                                                           -€0,5 m

                                                                                                                                                                     2,0
                                                                                                                                                                                 1,5

                                           H2 19 H2 H2 20                                                                                                        H2 19          H2 20

                                                                                                                             • Implementation of cost saving initiatives and benefit from
           • Strong hit of Covid-19 but month by month improvement                                                             governments support measures
           • Good performance of Materials activity

                                                                                                                                                                                            10
(1) Operating income before "Net depreciation, amortization and provisions", "Other items of operating income" and “Share in the results of associated companies”.
PRODUCTS DIVISION: LIMITED DECREASE DESPITE SECOND LOCKDOWN

                      Revenue (€m)                                                                                                   EBITDA1 (€m)
                                                     -€1.5 m

                                             12,8
                                                                   11,3                                                                                              10.7%        10.3%
                                                                                                                                                                     margin       margin

                                                                                                                                                                             -€0.2 m

                                                                                                                                                                       1,4             1,2

                                         H2 2019 H2 H2 2020
                                                                                                                                                                     H2 2019 H2H2 2020

            • Lower impact of the 2nd lockdown compared to the 1st one                                                   • EBITDA margin maintained above 10%

            • Recovery engaged with medical activities almost back to                                                    • Benefit from government support measures
              2019 level in Q4

                                                                                                                                                                                             11
(1) Operating income before "Net depreciation, amortization and provisions", "Other items of operating income" and “Share in the results of associated companies”.
SOUND BALANCE SHEET AT END-2020
              In € million

           Positive net cash position
           after a challenging year
           while continuing investments

                            1                                 1

            AVAILABLE CASH OF €22.5M AS OF END 2020

                                                                  12
1 Before   IFRS16 leases debt and including treasury shares
OUTLOOK : STRONG GROWTH IN 2021 & FOR THE NEXT
YEARS

                                             13
A GROWING MARKET FOR 3D PRINTING THROUGH SCALING OF APPLICATIONS

                                                                                        Prodways track record proves its capacity to capture market growth
                                                                                        by scaling new applications to industrial production

      ~€100 bn
    global market projected in 20291
                 vs ~€10 bn in 2021

                                                                                             Dental:                    Chiropody:                   Jewellery:
Positive trends supporting a strong valuation
     of 3D printing companies in the US
                                                                                        1 million aligners             50,000 insoles              250,000 jewels
                                                                                              / year                       / year                      / year
      +300% on average on one                   year2,
   Uptake not yet materialized in Europe

     1 Source   : Wohlers report 2020                                                                                                                           14
     2 Average    share price growth of major US 3D Printing players since 16/03/2020
STRONG STRATEGIC POSITION TO BENEFIT FROM SUPPORTING TRENDS

         A differentiating offer
1        Solutions on the whole value chain of 3D printing
                                                                    Software, Printers, Materials, Manufacturing

             1st grade performance for industrial production
2            for mass customized applications
                                                                           Technologies offering unique precision & speed on the market

                                                                                         R&D with Essilor for manufacturing lenses,
                  Development of new partnerships
    3             for new applications with significant potential
                                                                                         R&D with a leading dental player for new products
                                                                                         Opportunities in precision casting

                                                                                                                              15
GUIDANCE 2021 & FUTURE AMBITIONS: STRONG GROWTH IN 2021 & BEYOND

          2021                                   Beyond
     Double-digit
   revenue growth
            &                             Strong development
                                             of all activities
improving profitability
     starting in H1 2021

                                                                    16
Q&A

      17
You can also read